Utkan, T. Et Al. 2012. P 1 g 005 Effects of potent nitric oxide guanylyl cyclase activator and phosphodiesterase 5 inhibitor on cognitive deficits in diabetic rats. EUROPEAN NEUROPSYCHOPHARMACOLOGY , (Vienna, Austria), 207.

Utkan, T., Gacar, M. N., & Arıcıoğlu, F., (2012). P 1 g 005 Effects of potent nitric oxide guanylyl cyclase activator and phosphodiesterase 5 inhibitor on cognitive deficits in diabetic rats . EUROPEAN NEUROPSYCHOPHARMACOLOGY (pp.207). Vienna, Austria

Utkan, TİJEN, Mehmet Nejat Gacar, And Feyza Arıcıoğlu. "P 1 g 005 Effects of potent nitric oxide guanylyl cyclase activator and phosphodiesterase 5 inhibitor on cognitive deficits in diabetic rats," EUROPEAN NEUROPSYCHOPHARMACOLOGY, Vienna, Austria, 2012

Utkan, TİJEN Et Al. "P 1 g 005 Effects of potent nitric oxide guanylyl cyclase activator and phosphodiesterase 5 inhibitor on cognitive deficits in diabetic rats." EUROPEAN NEUROPSYCHOPHARMACOLOGY , Vienna, Austria, pp.207, 2012

Utkan, T. Gacar, M. N. And Arıcıoğlu, F. (2012) . "P 1 g 005 Effects of potent nitric oxide guanylyl cyclase activator and phosphodiesterase 5 inhibitor on cognitive deficits in diabetic rats." EUROPEAN NEUROPSYCHOPHARMACOLOGY , Vienna, Austria, p.207.

@conferencepaper{conferencepaper, author={TİJEN UTKAN Et Al. }, title={P 1 g 005 Effects of potent nitric oxide guanylyl cyclase activator and phosphodiesterase 5 inhibitor on cognitive deficits in diabetic rats}, congress name={EUROPEAN NEUROPSYCHOPHARMACOLOGY}, city={Vienna}, country={Austria}, year={2012}, pages={207} }